The chair of the first session of the joint meeting between the European Medicines Agency (EMEA) and The Organization for Professionals in Regulatory Affairs (TOPRA) in London this week was quick to point out that the event was not scheduled to coincide with last Friday’s announcement that European Commission (EC) responsibility for EMEA is finally [...]
The EU Pharma Switch